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Abstract
With the continued exponential expansion of publicly available genomic data and access to low-cost, high-
throughput molecular technologies for profiling patient populations, computational technologies and informatics
are becoming vital considerations in genomic medicine. Although cloud computing technology is being heralded
as a key enabling technology for the future of genomic research, available case studies are limited to applications
in the domain of high-throughput sequence data analysis. The goal of this study was to evaluate the computa-
tional and economic characteristics of cloud computing in performing a large-scale data integration and analysis
representative of research problems in genomic medicine. We find that the cloud-based analysis compares favor-
ably in both performance and cost in comparison to a local computational cluster, suggesting that cloud comput-
ing technologies might be a viable resource for facilitating large-scale translational research in genomic medicine.
Background
The intensely data-driven and integrative nature of
research in genomic medicine in the post-genomic era
presents significant challenges in formulating and testing
important translational hypotheses. Advances in high-
throughput experimental technologies continue to drive
the exponential growth in publicly available genomic
data, and the integration and interpretation of these
immense volumes of data towards direct, measureable
improvements in patient health and clinical outcomes is
a grand challenge in genomic medicine. Consequently,
genomic medicine has become rooted in and enabled by
bioinformatics, engendering the notion of translational
bioinformatics [1]. Translational bioinformatics is char-
acterized by the challenge of integrating molecular and
clinical data to enable novel translational hypotheses bi-
directionally between the domains of biology and medi-
cine [2,3]. In addition to the scientific challenges, the
dimensionality and scale of genomic data sets presents
statistical challenges, and also technical hurdles in gain-
ing access to the computational power necessary to test
even simple translational hypotheses using genomic
data. For example, public data repositories such as the
NCBI Gene Expression Omnibus (GEO) [4] enable
researchers to ask novel and important translational
questions such as, ‘Which genes are most likely to be
up-regulated specifically in cancers compared to all
other human diseases’ [5]? Given that GEO contains
hundreds of thousands of clinical microarray samples,
each with tens of thousands of gene abundance mea-
surements, even a straightforward analysis of these data
could require many billions or even trillions of
comparisons.
While some of these challenges may be overcome by
sophisticated computational techniques, raw computa-
tional power remains a substantial requirement that lim-
its the conduct of such analyses. Although the cost of
computing hardware has decreased substantially in
recent years, investments of tens or hundreds of thou-
sands of dollars are typically required to build and
maintain a substantial scientific computing cluster. In
addition to the hardware costs, sophisticated software to
enable parallel computation is typically required, and
staff must be hired to manage the cluster. Finally, sub-
stantial expenditures are required to pay for the utilities
(for example, electricity, cooling) required for cluster
operation. In this way, the computational requirements
of contemporary genomic medicine are limiting, because
access to the necessary computing power is restricted to
those with the individual or institutional resources
needed to install and maintain the necessary computa-
tional infrastructure. This unfortunately restricts the
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manner and scope of translational hypotheses that could
otherwise be formulated and tested by researchers who
do not have access to the necessary computational
resources. Outside of clinical science, many organiza-
tions are exploring or using cloud computing technology
to fulfill computational infrastructure needs.
Cloud computing potentially offers an efficient and
economical means to obtain the power and scale of
computation required to facilitate large-scale efforts in
translational data integration and analysis. The defini-
tion of cloud computing itself is not concrete due to the
many commercial interests involved. For the purposes
of this article, we define cloud computing as ‘a style of
computing in which dynamically scalable and often vir-
tualized resources are provided as a service over the
Internet’ [6]. Cloud computing is enabled by many tech-
nologies, but key among them is virtualization technol-
ogy, which allows entire operating systems to run
independently of the underlying hardware [7]. In most
cloud computing systems, the user is given access to
what appears to be a typical server computer. However,
the server is really just a virtual ‘instance’ running at
any one point on a large underlying hardware architec-
ture, which is made up of many independent CPUs and
storage devices. Viewed from an economic standpoint,
cloud computing can be understood as a utility, much
like water or electricity, where you only pay for what
you use. In this sense, cloud computing provides access
to a computational infrastructure on an on-demand,
variable cost basis, rather than a fixed cost capital
investment into physical assets.
Here, we present a case study evaluating the use of
cloud computing technologies for a translational bioin-
formatics analysis of a large cancer genomics data set
composed of matched replicate SNP genotype and gene
expression microarray assay samples for 311 cancer cell
lines, comprising 929 gene expression microarray sam-
ples and 622 SNP genotype array samples. We suggest
that the data analysis illustrated by this case study is
characteristic of computational challenges that might be
faced by modern clinical researchers who have access to
inexpensive high-throughput genomic assay technologies
for profiling their patient populations. Our goal was to
perform a statistical analysis to uncover expression
quantitative trait loci (eQTL; that is, genomic loci asso-
ciated with gene transcript abundance) that are common
across cancer types. This entailed a statistical analysis
whereby the genotype of each measured SNP was tested
against the expression levels of each measured gene
expression probe. The SNP platform used to generate
our data measured 500,568 SNPs, and the gene expres-
sion microarray platform measured gene expression
levels across 54,675 probes, requiring statistical evalua-
tion of more than 13 × 109 comparisons. We estimated
that it would take a single, modern server-class CPU
more than 5,000 days to complete the analysis. Here we
demonstrate the computational and economical charac-
teristics of conducting this analysis using a cloud-based
service, and contrast these characteristics with the com-
putational and economic characteristics of performing
the same analysis on a local institutional cluster.
Methods
Data
We downloaded the gene expression and genotyping
data of 311 cancer cell lines from caBIG [8]. The
mRNA expression of 54,675 probes in 929 samples was
measured on the Affymetrix U133 Plus 2.0 platform.
The genotypes of 500,568 SNPs in 622 DNA samples
were measured on the Affymetrix 500K platform and
analyzed using the oligo, pd.mapping250k.nsp, pd.map-
ping250k.sty R libraries in the Bioconductor [9].
Cloud computing setup
Amazon Web Services (AWS) [10] elastic compute
cloud (EC2) computing service was used for the analysis.
EC2 instances were managed using the free edition of
the RightScale Cloud Management Platform [11]. This
tool was chosen because it provides visual interfaces for
managing the cloud servers and executing scripts, which
would be a plausible scenario for an investigator that
lacked advanced computational abilities. All virtual
instances used in the analysis were of the m1.large EC2
instance type [12] running 64-bit CentOS Linux version
5.2 [13]. This instance type was chosen because it was
determined to be the most economical choice given the
amount of system memory required (>12 GB) by the
analysis. A total of 100 EC2 instances were used for the
analysis. One of these instances served as the job control
and data-partitioning server. This server used the
MySQL relational database server v.5.1 [14] to store
accounting and job control data pertaining to the execu-
tion start and stop times of each compute node, as well
as the comparison indices issued to each compute node.
The compute nodes were provisioned using the Right-
Scale dashboard using a custom startup script that
installed the required version of the R statistical com-
puting environment, as well as additional R packages
upon server initialization. In particular, the RMySQL
package [15] was used to communicate with the data-
base running on the data-partitioning server, and the ‘ff’
package [16] was used to store data partitions as mem-
ory-mapped, disk-based data frames to enable efficient
use of compute node system memory.
Local cluster setup
We used a dedicated 240 core High Performance Com-
pute Cluster based on the Hewlett Packard C-class
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BladeSystem attached to 15 TB storage area network.
Each compute node has dual socket quad-core Intel
E5440 Harpertown CPUs for a total of 8 processors per
node with 16 GB of ram and interconnected with 4 ×
DDR InfiniBand switched fabric. The cluster uses the
Platform HPC Workgroup Manager cluster operating
system with Platform LSF cluster distributed workload
management. The cluster is hosted in a water-cooled
rack at Stanford ITS Forsythe data center, a secure
monitored facility with uninterruptible power supply
(UPS) and standby backup power generators. The analy-
sis was restricted to 198 of the 240 available CPUs to
enable an equitable comparison with the cloud-based
analysis.
Statistical analysis
All statistical analysis were performed using the R statis-
tical computing environment [17]. Putative eQTLs were
evaluated using a one-way analysis of variance
(ANOVA) test. For each SNP-expression probe pair, we
grouped the expression values for that probe across all
samples according to their respective genotype for the
SNP as denoted by homozygous major (AA), homozy-
gous minor (aa) and heterozygous (Aa). Using the geno-
type designations as factors, we carried out a one-way
ANOVA to test the null hypothesis that the means of
the expression levels across all three genotype categories
were equal. P-values from the one-way ANOVA were
corrected using the Bonferroni method. If the one-way
ANOVA rejected the null hypothesis after correction,
we determined that the SNP was an eQTL for the parti-
cular expression probe.
Cost estimation
Costs for the local cluster were estimated by spreading
capital costs of hardware and software over a 3-year per-
iod, representing the typical service lifetime of computer
hardware in academic research. Per-year operational
costs were projected assuming a 5% cost inflation rate
each year. An average yearly cost was estimated from
the total capital and operational costs estimated over
the 3-year period, and from this we computed an hourly
cost for operating the cluster, which was divided by the
number of CPUs in the cluster to estimate the per-
CPU/per-hour cost of operating the local cluster.
Results
From our data set of matched pairs of 622 SNP geno-
type arrays and 929 gene expression microarrays assayed
as matched pairs across 311 cancer cell lines, we evalu-
ated 13,029,271,200 SNP-expression probe pairs to eval-
uate if any of the SNPs could be considered as eQTLs
based on experimental measurements across all samples.
Each pair-wise comparison comprised approximately
700 genotype versus expression data points, thereby
generating >9.0 × 1012 total data points. The total set of
pair-wise SNP-expression comparisons was broken into
99 equal subsets, which were evaluated in parallel across
99 individual compute node instances. One additional
server instance served as the data and index server that
distributed the comparison sets to each node, and also
collected operational statistics (for example, eQTL ana-
lysis start/stop times) from each of the compute nodes
(Figure 1). Each compute node executed two separate
eQTL analysis processes that ran in parallel. Each pro-
cess performed eQTL analysis on one of the data sub-
sets, evaluating 131 × 106 SNP-expression probe pairs in
sequence. Under this scheme, the analysis was distribu-
ted across 198 computational processes executing across
99 compute node instances in the cloud infrastructure.
This computational strategy was executed on the AWS
[10] EC2 infrastructure using virtual server instances,
and also on our local institutional compute cluster with
similar operating system specifications to the EC2
instances. The analysis was restricted to use only 198 of
the 240 available CPU cores on the local cluster to
allow for an equitable performance comparison.
The eQTL analysis completed in approximately 6 days
on both systems (Table 1), with the local cluster com-
pleting the computation 12 hours faster than the virtual
cloud-based cluster. The total cost for running the ana-
lysis on the cloud infrastructure was approximately
three times the cost of the local cluster (Table 2). The
final results of the eQTL analysis yielded approximately
13 × 109 one-way ANOVA P-values, respective to the
total number of SNP-expression probe pairs that were
evaluated. After correcting the one-way ANOVA
P-values using the Bonferroni method, 22,179,402
putative eQTLs were identified.
Discussion
Using a real-world translational bioinformatics analysis
as a case study, we demonstrate that cloud computing is
a viable and economical technology that enables large-
scale data integration and analysis for studies in geno-
mic medicine. Our computational challenge was moti-
vated by a need to discover cancer-associated eQTLs
through integration of two high-dimensional genomic
data types (gene expression and genotype), requiring
more than 13 billion distinct statistical computations.
It is notable that execution of our analysis completed
in approximately the same running time on both sys-
tems, as it could be expected that the cloud-based analy-
sis would take longer to execute due to possible
overhead incurred by the virtualization layer. However,
in this analysis, we find no significant difference in
execution performance between a cloud-based or local
cluster. This may be attributable to our design of the
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analysis code, which made heavy use of CPU and system
memory in an effort to minimize disk input/output. It is
possible that an analysis that required many random
seeks on the disk could have realized a performance
disparity between the two systems.
Although the total cost for running the analysis on the
cloud-based system was approximately three times more
expensive compared to the local cluster, we assert that
the magnitude of this cost is well within reach of the
research (operational) budgets of a majority of clinical
researchers. There are intrinsic differences between
these approaches that prevent us from providing a com-
pletely accurate accounting of costs. Specifically, we
chose to base our comparison on the cost per CPU
hour because it provided the most equivalent metric for
comparing running-time costs. However, because we are
comparing capital costs (local cluster) to variable costs
(cloud), this metric does not completely reflect the true
cost of cloud computing for two reasons: we could not
use a 3-year amortized cost estimate for the cloud-based
system, as done for the local cluster; and the substantial
delay required to purchase and install a local cluster was
not taken into account. As these factors are more likely
to favor the cloud-based solution, it is possible that a
more sophisticated cost analysis would bring the costs
of the two approaches closer to parity.
There are several notable differences in the capabilities
of each system that give grounds for the higher cost of
the cloud-based analysis. First, there are virtually no
startup costs associated with the cloud-based analysis,
whereas substantial costs are associated with building a
local cluster, such as hardware, staff, and physical hous-
ing. Such costs range in the tens to hundreds of thou-
sands of dollars, likely making the purchase of a local
cluster prohibitively expensive to many. It can take
months to build, install and configure a large local clus-
ter, and therefore there is also the need to consider the
non-monetary opportunity costs incurred during initia-
tion of a local cluster. The carrying costs of the local
cluster that persist upon conclusion of the analysis
should also be considered. The cloud-based system
offers many technical features and capabilities that are
not matched by the local cluster. Chief among these is
the ‘elastic’ nature of the cloud-based system, which
allows it to scale the number of server instances based
on need. If there was a need to complete this large ana-
lysis in the time-span of a day, or even several hours,
the cloud-based system could have been scaled to
Figure 1 Schematic illustration of the computational strategy utilized for the cloud-based eQTL analysis. One hundred virtual server
instances are provisioned using a web-based cloud control dashboard. One of the virtual server instances served as a data distribution and job
control server. Upon initialization, the compute nodes would request a subset partition of eQTL comparisons and insert timestamp entries into a
job accounting database upon initiation and completion of the eQTL analysis subset it was administered.
Table 1 Performance and economic metrics for eQTL
analysis for cloud-based and local compute clusters
eQTL analysis on AWS
cloud
eQTL analysis on local
cluster
Running time 6 days 0.1 hours 5 days 11.9 hours
Total CPUs 198 198
Cost per CPU $0.19 $0.06
Total analysis
cost
$5,417.28 $1,710.00
Per CPU costs for the local cluster were estimated using the cost structure
detailed in Table 2.
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several hundred server instances to accelerate the analy-
sis, whereas the local cluster size is firmly bound by the
number of CPUs installed. A related feature of the
cloud is the user’s ability to change the computing hard-
ware at will, such as selecting fewer, more powerful
computers instead of a larger cluster if the computing
task lends itself to this approach.
Other features unique to the cloud include ‘snapshot-
ting’, which allows whole systems to be archived to per-
sistent storage for subsequent reuse, and ‘elastic’ disk
storage that can be dynamically scaled based on real-
time storage needs. A feature of note that is proprietary
to the particular cloud provider used here is the notion
of ‘spot instances’, where a reduced per-hour price is set
for an instance, and the instance is launched during per-
iods of reduced cloud activity. Although this feature may
have increased the total execution time of our analysis,
it might also reduce the cost of the cloud-based analysis
by half depending on market conditions. Clearly, any
consideration for the disparities in the costs between the
two systems must consider additional features and tech-
nical capabilities of the cloud-based system.
While we find that the cost and performance charac-
teristics of the cloud-based analysis are accommodat-
ing to translational research, it is important to
acknowledge that substantial computational skills are
still required in order to take full advantage of cloud
computing. In our study, we purposefully chose a less
sophisticated approach of decomposing the computa-
tional problem by simple fragmentation of the compar-
ison set. This was done to simulate a low-barrier of
entry approach to using cloud computing that would
be most accessible to researchers lacking advanced
informatics skills or resources. Alternatively, our analy-
sis would likely have been accelerated significantly
through utilization of cloud-enabled technologies such
as MapReduce frameworks and distributed databases
[18]. It should also be noted that while this manuscript
was under review, Amazon announced the introduc-
tion of Cluster Computer Instances intended for high
performance computing applications [19]. Such com-
puting instances could further increase accessibility to
high-performance computing in the cloud for non-
specialist researchers.
There are serious considerations that are unique to
cloud computing. Local clusters typically benefit from
dedicated operators who are responsible for maintaining
computer security. By contrast, cloud computing allows
free configuration of virtual machine instances, thereby
sharing the burden of security with the user. Second,
cloud computing requires the transfer of data, which
introduces delays and can lead to substantial additional
costs given the size of many data sets used in transla-
tional bioinformatics. Users will need to consider this
aspect carefully before adopting cloud computing. An
additional data-related limitation we faced repeatedly
with our provider was a 1-terabyte limit on the size of
the virtual disks.
However, the most significant impediment facing bio-
medical researchers wishing to adopt cloud computing
involves the software environment for designing the
computing environment and running the experiments.
We believe efforts for fully exposing the capabilities of
cloud-computing environments at the application level
are key to enhancing the democratizing effect of cloud
computing in genomic medicine. Specifically, intuitive
and scalable software tools are needed to enable clini-
cian scientists at the forefront of medical discovery to
leverage fully the vast resources of public data and
cloud-based computing infrastructure. Cloud-based
tools should be specifically oriented to address the parti-
cular modes of inquiry of clinician scientists towards
enabling unified biological and clinical hypothesis eva-
luation. Rather than present the clinical investigator
with a collection of bioinformatics tools (that is, the
‘toolbox’ approach), we believe clinician-oriented, cloud-
based translational bioinformatics systems are key to
facilitating data-driven translational research using cloud
computing.
It is our hope that by demonstrating the utility and
promise of cloud computing for enabling and facilitating
translational research, investigators and funding agencies
will commit efforts and resources towards the creation
of open-source software tools that leverage the unique
Table 2 Cost structure used to estimate cost rate for local compute cluster CPUs
Category Cost year 1 Cost year 2 Cost year 3 Total cost over 3 years Average cost per year Average cost per hour
Hardware and support $56,667 $56,667 $56,667 $170,000 $56,667
Software licensing $5,000 $5,000 $5,000 $15,000 $5,000
Server hosting $23,424 $25,766 $28,343 $77,533 $25,844
Personnel $43,500 $45,675 $47,959 $137,134 $45,711
Entire cluster $15.21
Per CPU @240 CPUs $0.06
Estimates are based on real-world costs associated with the local compute cluster used as the basis for comparison in this study. A per-CPU/per-hour cost was
used as the basis for comparison with the cloud-based system.
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characteristics of cloud computing to allow for upload-
ing, storage, integration and querying across large repo-
sitories of public and private molecular and clinical data.
In this way, we might realize the formation of a bio-
medical computing commons, enabled by translational
bioinformatics and cloud computing, that empowers
clinician scientists to make full use of the available
molecular data for formulating and evaluating important
translational hypotheses bearing on the diagnosis,
prognosis, and treatment of human disease.
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